-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 31, Tengsheng Boyao Biotechnology Co.
Data showed a dose-dependent reduction in HBV surface antigen (HBsAg) levels in Chinese patients with chronic HBV infection after two doses of BRII-835 (VIR-2218), and decreased HBsAg levels in both HBeAg-negative and HBeAg-positive patients to a similar degree